Compare HeyElsa (ELSA) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HeyElsa vs Enzyme — how do they compare? HeyElsa trades at Rp845.3 (market cap Rp215,74M, Rp66,77M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: HeyElsa is the larger of the two by market cap, and HeyElsa's supply is capped (255,6M / 1B ELSA (26%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold HeyElsa for 6 Days and Enzyme for 29 Days on average.
| ELSA | MLN | |
|---|---|---|
Market Cap | Rp215,74M | Rp134,13M |
Volume (24h) | Rp66,77M | Rp104,56M |
Circulating Supply | 255,6M / 1B ELSA (26%) | 3,3M MLN |
Typical Hold Time | 6 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HeyElsa (ELSA) is trading at Rp927.41 with a bearish technical signal, positioned near the pivot point of Rp924. The asset has a market cap of Rp239.34 million and a circulating supply of 255,600 tokens out of a maximum 1 million, indicating a 26% circulation rate. No major protocol updates or ecosystem developments were noted recently.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from support levels, but risks involve low market cap volatility and lack of recent fundamental catalysts. Investors should monitor trading volume and on-chain activity for signs of momentum shifts.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HeyElsa
HeyElsa is an AI crypto assistant that converts natural-language commands into optimized on-chain actions. It enables intent-based execution for tasks like swaps and staking, handles routing and risk checks, and supports multiple chains including Ethereum, Solana, and Base. The platform also offers MPC wallets and onboarding tools to simplify DeFi for new users.
Read more on ELSA →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
